ABOS
Acumen Pharmaceuticals Inc
2.60$
-2.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
Acumen Pharmaceuticals Inc (ABOS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -116 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -6.8 | -7.5 | -18 | -35 | -43 | -86 | -116 | |
| 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | -0.8 | |
| 0.2 | 0.2 | 0.9 | 3.1 | 6.1 | 9.6 | 9.9 | |
| 0.3 | -0.4 | 82 | 3.1 | – | – | – | |
| 0.8 | 0.3 | 0.3 | 4.0 | 3.9 | 12 | -5.1 | |
| 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.1 | |
| -104 | -104 | -104 | 39 | -172 | 48 | 134 | |
| – | – | – | – | 0.0 | 0.0 | – | |
| – | – | 170 | 3.9 | 0.0 | 0.0 | -0.1 | |
| – | – | – | 0.0 | 30 | -0.7 | 0.0 | |
| 6.2 | 45 | 200 | 3.9 | 152 | 6.9 | 0.0 | |
| -0.6 | 37 | 78 | 7.9 | -63 | -31 | 18 | |
| -6.8 | -7.5 | -18 | -35 | -43 | -86 | -116 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.